Icon (NASDAQ:ICLR – Get Free Report) and Selectis Health (OTCMKTS:GBCS – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership.
Risk & Volatility
Icon has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, Selectis Health has a beta of -1.07, suggesting that its stock price is 207% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of current ratings for Icon and Selectis Health, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Icon | 3 | 6 | 9 | 0 | 2.33 |
| Selectis Health | 0 | 0 | 0 | 0 | 0.00 |
Institutional and Insider Ownership
95.6% of Icon shares are held by institutional investors. 44.0% of Icon shares are held by company insiders. Comparatively, 15.2% of Selectis Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Icon and Selectis Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Icon | 5.35% | 8.73% | 4.96% |
| Selectis Health | -2.45% | N/A | -3.03% |
Earnings & Valuation
This table compares Icon and Selectis Health”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Icon | $8.25 billion | 1.54 | $229.34 million | $5.62 | 29.44 |
| Selectis Health | $41.44 million | 0.40 | -$1.02 million | ($0.34) | -16.00 |
Icon has higher revenue and earnings than Selectis Health. Selectis Health is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.
Summary
Icon beats Selectis Health on 14 of the 14 factors compared between the two stocks.
About Icon
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.
About Selectis Health
Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.
Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.
